| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |